OrganiGram Could Climb Higher, but You Need Discipline Before Buying

Here's how to play OGI stock right now.

Green Growth Brands Could Be at a Level to Probe the Long Side

Let's take a look at the charts.

Cannabis Q&A: Greenlane's IPO Gives It the Green Light for Growth

Recently public company is the leading distributor of premium vaporization products and consumption accessories in the U.S.

Canaccord Raises Outlook for Cannabis Growth in the U.S.

Still, the firm rates the companies mentioned as speculative buys.

Constellation Brands Is Flexing Its Beer Muscles - And Upside Potential

Management's disappointment in Canopy Growth is akin to a coach expressing his displeasure with a prized rookie.

Constellation Brands Could Trade Sideways - Watch the OBV Line for Bullish Clues

Let's see if we can identify the next sustained move.

Cannabis Q&A: Elixinol Is a Hemp/CBD Player You Should Know About

It is important to expand your understanding beyond a few companies or a single concept.

Constellation Brands Remains Beer Dependent as it Transforms Itself

Changes will come as they move their wine and spirits business to the 'high end', and develop the activities of Canopy Growth, which promises cannabis-infused drinks.

5 Cannabis ETFs to Fire Up Your Portfolio

Two of them are brand new.

Prohibition and the Paradoxical Proclivity of Cannabis Consumption

Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?